The stem cell therapy market size is expected to be worth USD 59.70 billion by 2035, increasing from USD 18.13 billion in ...

Many biological functions are regulated by the switching on and off of mechanisms triggered by the matching of a keyhole ...

Pasca Lab specializes in growing three-dimensional organoid models from reprogrammed stem cells, which capture molecular changes during fetal brain-like development. Because the human brain cannot be ...

Axol Bioscience Ltd. (Axol), a leading provider of induced pluripotent stem cell (iPSC) technologies for drug discovery and ...

Pharma giant GSK is launching a five-year collaboration with The Jackson Laboratory–New York Stem Cell Foundation Collaborative (JAX-NYSCF) to advance human cellular models of neurodegenerative ...

A Cambridge-based biotech specialising in human induced pluripotent stem cell (iPSC) technologies has taken on the ophthalmology business of a drug discovery partner in Newcastle.

Axion BioSystems’ Letter of Intent for its Human iPSC-Cardiomyocyte MEA Assay for Prediction of Clinical Cardiovascular ...

A triple combination therapy identified using newly developed cell models is showing promise for treating sporadic ALS, per a study.

Bionano Symposium 2026 continues with Day 3: OGM Making its Mark in Constitutional Genetic Disorders on February 25, 2026, from 7:00-10:00 AM PT. Attendees may also explore scientific posters ...

Leonard Zon, professor of stem cell and regenerative biology and Grousbeck Professor of Pediatrics at Harvard Medical School, has been awarded the 2026 March of Dimes Richard B. Johnston Jr., MD Prize ...

Jackson Laboratory entered a five-year research deal with multinational pharmaceutical company GSK to study Alzheimer’s disease using stem cells. The collaboration aims to develop stem cell-based ...

In this inaugural event we are delighted to feature an exclusive fireside chat with renowned stem cell pioneer and organoid researcher Hans Clevers, MD, PhD, of the Hubrecht Institute in the ...